Virtu Financial’s Repare Therapeutics RPTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-15,488
Closed -$40K 2209
2025
Q4
$40K Buy
+15,488
New +$31.2K ﹤0.01% 1330
2025
Q2
Sell
-12,222
Closed -$12K 1970
2025
Q1
$12K Buy
+12,222
New +$14.7K ﹤0.01% 1164
2022
Q3
Sell
-12,519
Closed -$175K 2161
2022
Q2
$175K Buy
+12,519
New +$147K 0.01% 795

Virtu Financial's RPTX Position: Q1 2026 in Review

Virtu Financial sold out of Repare Therapeutics (RPTX) in Q1 2026, closing a stake of 15,488 shares — an estimated $40K sold.

Virtu Financial first reported a position in RPTX in Q2 2022 and held it in 3 quarters. The position peaked at $175K in Q2 2022. 0 funds tracked by Wall St. Rank hold RPTX as of Q1 2026.

  • Virtu Financial reported no remaining Repare Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Virtu Financial sold 15,488 Repare Therapeutics shares in Q1 2026, an estimated $40K.
  • Virtu Financial first reported a position in Repare Therapeutics in Q2 2022 and held it in 3 quarters.
  • Virtu Financial's Repare Therapeutics position peaked at $175K in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Repare Therapeutics as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.